The biotech healthcare company makes devices and pharmaceuticals that treat hemophilia, immune disorders, infectious diseases, and kidney disease.
Company Info
| CEO | Jose E. Almeida |
| CEO Title | Chairman, President & Chief Executive Officer |
| Sector | Health Care |
| Industry | Medical Products and Equipment |
| HQ Location | Deerfield, IL |
| Website | www.baxter.com |
| Years on Fortune 500 List | 23 |
| Employees | 48,000 |
Key Financials (Last Fiscal Year)
| Revenues ($M) | $10,163 |
| Profits ($M) | $4,965 |
| Assets ($M) | $15,546 |
| Total Stockholder Equity ($M) | $8,290 |
| Market Value — as of March 31, 2017 ($M) | $28,106 |
Profit Ratios
| Profit as % of Revenues | 48.9% |
| Profits as % of Assets | 31.9% |
| Profits as % of Stockholder Equity | 59.9% |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 901 |
| EPS % Change (from 2015) | 411.9% |
| EPS % Change (5 year annual rate) | 18.4% |
| EPS % Change (10 year annual rate) | 15.5% |
Total Return
| Total Return to Investors (2016) | 17.6% |
| Total Return to Investors (5 year, annualized) | 12.9% |
| Total Return to Investors (10 year, annualized) | 8% |
